AMD3100 octahydrochloride hydrate

• Catalog No.: A5602
• CAS Number: 155148-31-5(anhydrous)
• M. F.: C28H64Cl8N8O
• M. W.: 812.48476
• Purity: ≥97% (NMR)
• Storage: desiccated

SYNONYMS

• IUPAC name: 1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane hydrate octahydrochloride
• IUPAC Traditional name: plerixafor hydrate octahydrochloride
• Synonyms: SID791; Plerixafor; JM3100; 1,1′-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride

DATABASE IDS

• CAS Number: 155148-31-5(anhydrous)
• PubChem SID: 24724394

PROPERTIES

• Empirical Formula (Hill Notation): C28H54N8 · 8HCl · xH2O
• Purity: ≥97% (NMR)
• Apperance: solid
• Solubility: H2O: ≥10 mg/mL, clear
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• Storage Condition: desiccated
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (简体中文)

Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
AMD3100 is a highly specific chemokine receptor CXCR4 antagonist.
Application
AMD3100 is a highly specific chemokine receptor CXCR4 antagonist. AMD3100 has been used in a study to determine the blockade of CXCR4 in oral squamous cell carcinoma and inhibition of lymph node metastases.

Description (English)

Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
AMD3100 is a highly specific chemokine receptor CXCR4 antagonist.
Application
AMD3100 is a highly specific chemokine receptor CXCR4 antagonist. AMD3100 has been used in a study to determine the blockade of CXCR4 in oral squamous cell carcinoma and inhibition of lymph node metastases.